^SAMPLE = GSM795942!Sample_title = Sample 32P_ependymoma-250knsp!Sample_geo_accession = GSM795942!Sample_status = Public on Feb 09 2012!Sample_submission_date = Sep 13 2011!Sample_last_update_date = Feb 09 2012!Sample_type = genomic!Sample_channel_count = 1!Sample_source_name_ch1 = primary ependymoma DNA sample from patient 32!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = patient: 32!Sample_characteristics_ch1 = disease state: ependymoma!Sample_characteristics_ch1 = ependymoma status: primary!Sample_characteristics_ch1 = gender: female!Sample_characteristics_ch1 = location: supratentorial (ST)!Sample_characteristics_ch1 = age: 11.4yrs!Sample_characteristics_ch1 = tumour grade: World Health Organisation Grade III!Sample_characteristics_ch1 = patient outcome: Alive and no disease progression!Sample_characteristics_ch1 = tumour 1q gain status: No 1q gain!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted snap frozen tumour tissue and mononuclear cell preparations  from peripheral blood, using a standard phenol/chloroform/isoamyl alcohol method. DNA quality and quantity was assessed using a Nandrop spectrophotometer and agarose gel electrophoresis.!Sample_label_ch1 = Biotin!Sample_label_protocol_ch1 = As per manufacturer (Affymetrix)!Sample_hyb_protocol = DNA was restriction digested, PCR amplified, fragmented, labelled and hybridised to each array according to the manufacturer's instructions.!Sample_scan_protocol = The Arrays were then washed using Affymetrix fluidics stations, and scanned using the Gene Chip Scanner 3000.!Sample_description = primary ependymoma, female, ST, 11.4yrs!Sample_description = S0398FL0018 nsp!Sample_description = Hybridized to 250K_Nsp!Sample_data_processing = CEL files and CHP files (generated by Affymetrix GTYPE using the BRLMM algorithm) were processed by CNAG. Normalization was performed using the constitutional samples. Data processing was performed as described in Miller et al Neuro Oncol 2011;13(8):866-79.!Sample_data_processing = Primary data description: Genotype Call (SNP call): AA, AB, BB, NC, and NoCall;!Sample_platform_id = GPL3718!Sample_contact_name = John-Paul,,Kilday!Sample_contact_email = mgzjk@exmail.nottingham.ac.uk!Sample_contact_phone = 0115 8230718!Sample_contact_laboratory = D18!Sample_contact_department = CBTRC!Sample_contact_institute = University of Nottingham !Sample_contact_address = Derby Road!Sample_contact_city = Nottingham!Sample_contact_zip/postal_code = NG7 2UH!Sample_contact_country = United Kingdom!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795942/suppl/GSM795942_S0398FL0018-250knsp.CEL.gz!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795942/suppl/GSM795942_S0398FL0018-250knsp.brlmm.chp.gz!Sample_series_id = GSE32101!Sample_data_row_count = 262314#ID_REF = PROBE SET NAME#VALUE = CALL#CONFIDENCE = #FORCED CALL = #CONTRAST = #STRENGTH = !sample_table_beginID_REF	VALUE	CONFIDENCE	FORCED CALL	CONTRAST	STRENGTHAFFX-2315060	AB	0.000127	AB	-0.067845	11.523859AFFX-2315061	AB	0.012335	AB	0.188197	10.481004AFFX-2315062	AA	0.012720	AA	0.566785	9.888988AFFX-2315057	AB	0.002053	AB	-0.142609	10.166885AFFX-2315058	AB	0.001759	AB	0.225247	10.924121AFFX-2315059	AB	0.011498	AB	0.297746	10.058035AFFX-2315063	BB	0.004622	BB	-0.811666	10.369948AFFX-2315064	AB	0.007310	AB	0.149860	10.113318AFFX-2315065	AB	0.001274	AB	-0.098173	9.912608AFFX-2315066	BB	0.030151	BB	-0.621232	9.932131AFFX-2315067	BB	0.017526	BB	-0.555680	10.877475AFFX-2315068	BB	0.000856	BB	-0.603358	10.013100AFFX-2315069	AA	0.000980	AA	0.797200	10.204841AFFX-2315070	AB	0.004371	AB	-0.108049	9.959411AFFX-2315071	AB	0.017557	AB	-0.015280	9.409633AFFX-2315072	AA	0.002227	AA	0.554255	10.411322AFFX-2315073	AB	0.004693	AB	0.157364	10.201189AFFX-2315074	BB	0.025413	BB	-0.650634	9.737874AFFX-2315075	AB	0.030439	AB	-0.178003	11.190763AFFX-2315076	BB	0.012068	BB	-0.517363	10.099437!sample_table_end